Filing Details
- Accession Number:
- 0001181431-11-036619
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-14 19:19:52
- Reporting Period:
- 2011-06-10
- Filing Date:
- 2011-06-14
- Accepted Time:
- 2011-06-14 19:19:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1389870 | Omni Bio Pharmaceutical Inc. | OMBP | Biological Products, (No Disgnostic Substances) (2836) | 208097969 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1011938 | Mark Steven Bathgate | 5350 South Roslyn Suite 430 Greenwood Village CO 80111 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-10 | 20,000 | $0.00 | 45,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants (Right to Buy) | Acquisiton | 2011-06-10 | 20,000 | $0.00 | 20,000 | $2.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2011-06-10 | 2016-06-10 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 604,000 | Indirect | By wife |
| Common Stock | 976,750 | Indirect | By GVC Capital LLC |
| Common Stock | 30,000 | Indirect | By Bathgate Family Partnership Ltd. |
| Common Stock | 50,000 | Indirect | By daughter |
Footnotes
- The reporting person purchased 20,000 Units from the issuer in a private placement transaction for $1.25 per Unit. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.
- Includes 25,250 shares that were previously reported as being held directly by the reporting person.
Billionaire Hedge Funds
